Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Sep 24, 2026
Why Is Trio-Tech International (TRT) Stock Down -20.61% Today?

Why Is Trio-Tech International (TRT) Stock Down -20.61% Today?

Key Takeaways

  • TRT shares tumbled roughly 20.61% intraday, falling to about $9.09 from a prior close of $11.45.
  • The decline marks a sharp momentum reversal after a months-long rally that had lifted the stock well over 100% and to a multi-year high.
  • Elevated valuation, heavy customer concentration, and compressed profit margins have drawn increasingly bearish scrutiny from analysts.
  • A roughly $10 million registered direct offering completed earlier in the year has kept a dilution overhang on the stock.
  • Broad selling in small-cap semiconductor names and profit-taking amplified the move in a thinly traded, high-beta stock.
  • Traders are watching upcoming fiscal first-quarter results, order momentum for AI-related burn-in boards, and whether key technical levels hold.

Opening Summary

Trio-Tech International (TRT), a California-based provider of semiconductor back-end testing services, burn-in and reliability test equipment, and industrial electronics solutions, saw its shares plunge sharply in Thursday's session. The stock was last trading near $9.09, down about $2.36, or 20.61%, from its previous closing price of $11.45. The move unwound a portion of the stock's dramatic advance and reflected a wave of selling pressure across the small-cap semiconductor testing space, compounded by lingering concerns over valuation and customer concentration.

A Sharp Reversal After a Parabolic Rally

The most immediate driver behind the decline appears to be profit-taking following a remarkable run-up. TRT had surged more than 120% over the preceding six months and climbed from a 52-week low near $2.56 to a high around $21.38, as investor enthusiasm for artificial intelligence and automotive semiconductor demand boosted the stock. With shares trading at a trailing price-to-earnings multiple far above the broader semiconductor industry average, the valuation had become stretched by nearly any conventional measure. When momentum faded, a flood of sellers emerged, and the stock gave back a sizable share of its gains in a single session.

Customer Concentration and Valuation Concerns

Bearish commentary has increasingly focused on the company's reliance on a small number of large customers. One key customer has been reported to account for more than 40% of revenue and to have driven the overwhelming majority of the company's recent growth, raising questions about the sustainability of the expansion. That concentration risk, combined with an elevated valuation multiple, has prompted cautious-to-negative assessments from some research providers. These concerns appear to have encouraged a round of selling among investors who had ridden the rally higher and were looking to lock in profits.

Margin Compression and Profitability Pressure

Despite robust top-line growth, Trio-Tech's profitability has remained under pressure. A larger mix of lower-margin, high-volume testing services has weighed on gross margin, which has compressed to roughly the mid-teens on a percentage basis, and the company has posted operating losses in recent quarters even as revenue expanded strongly. While management has emphasized demand-driven capacity expansion in Malaysia to support AI and automotive testing programs, the near-term margin squeeze has made the stock vulnerable to sharp corrections when sentiment shifts.

Market Context and Trading Activity

The sell-off unfolded on elevated trading activity, consistent with a high-beta, relatively thinly traded small-cap name. The decline was more pronounced than moves in the broader market and diverged from the performance of many large-cap semiconductor peers, suggesting company-specific factors and momentum dynamics, rather than a single macro event, drove the action. The reversal also occurred shortly after the company completed its transfer of listing to the Nasdaq Global Market, a period that can bring heightened volatility as the shareholder base adjusts. Technically, the drop pushed shares through several near-term support levels and back toward price ranges last seen earlier in September.

What Comes Next for TRT

Investors will be watching the company's next quarterly report for signs that AI- and automotive-driven testing demand continues to translate into sustained revenue and, eventually, margin recovery. Key areas of focus include follow-on orders for high-performance burn-in boards supporting next-generation AI GPU platforms, progress on the Malaysian capacity expansion, and any improvement in gross margins as the revenue mix evolves. Risks remain, however: customer concentration, semiconductor industry cyclicality, dilution from the completed equity offering, and the potential for further volatility in a small-cap name that has shown it can move dramatically in both directions.

Trending AI Robots

For traders seeking a more systematic approach to navigating fast-moving stocks like TRT, Tickeron's Trending AI Robots page offers a curated view of the platform's strongest-performing automated strategies. Tickeron hosts hundreds of AI trading bots covering thousands of tickers, but only those demonstrating the strongest results under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and the symbols they trade. Explore the page to see which AI-driven approaches are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TRT

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for TRT turns positive, indicating new upward trend

TRT saw its Momentum Indicator move above the 0 level on September 15, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 111 similar instances where the indicator turned positive. In 89 of the 111 cases, the stock moved higher in the following days. The odds of a move higher are at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for TRT just turned positive on September 17, 2026. Looking at past instances where TRT's MACD turned positive, the stock continued to rise in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.

TRT moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TRT crossed bullishly above the 50-day moving average on September 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.

Following a +3.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRT advanced for three days, in 198 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

TRT broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TRT entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. TRT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock slightly better than average.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.247) is normal, around the industry mean (8.083). P/E Ratio (244.889) is within average values for comparable stocks, (165.446). TRT's Projected Growth (PEG Ratio) (0.020) is slightly lower than the industry average of (0.821). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (1.604) is also within normal values, averaging (27.897).

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 62.46B. The market cap for tickers in the group ranges from 326.86K to 653.1B. ASML holds the highest valuation in this group at 653.1B. The lowest valued company is AVSR at 326.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 5%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 25%. COHU experienced the highest price growth at 26%, while SMTK experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -4%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -42%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 35
Price Growth Rating: 48
SMR Rating: 71
Profit Risk Rating: 61
Seasonality Score: -31 (-100 ... +100)
View a ticker or compare two or three
TRT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company that engages in semiconductor testing and manufacturing

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interact to see
Advertisement
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.